Literature DB >> 10624342

Radiation burden to paediatric patients due to micturating cystourethrography examinations in a Dutch children's hospital.

F W Schultz1, J Geleijns, H C Holscher, J Weststrate, H M Zonderland, J Zoetelief.   

Abstract

Micturating cystourethrography (MCU) examinations of paediatric patients in a major Dutch children's hospital (JKZ) were evaluated to generate quantitative information on effective dose (E). A standard examination involves three radiographs plus fluoroscopy. Observed total dose-area product (DAP) for 84 children increased, on average, with increasing age class from 0.2 to 2.2 Gy cm2. In 11 cases, separate DAP per view was measured; enabling determination, per view, of organ (CF) and effective (CE) dose conversion factors, i.e. dose per unit of DAP. Monte Carlo simulation of photon transport in male and female mathematical phantoms was applied for newborn, 1 year, 5 year, 10 year and 15-year-old patients, and interpolated for other ages. CE per view decreases with increasing age class, yielding about a factor of 10 difference between the extremes of the range. Female values are usually some 20-30% above male ones. CE for one of the views appeared to be representative for the complete examination and was used to estimate total E for each patient. Averaged per age class, E remains approximately constant at 0.3-0.4 mSv, although a tendency to increase with increasing age exists, for females in particular. Within an age class, individual patients may differ in E by a factor of two up to six. Stomach, lower large intestine, bladder wall, liver and ovaries receive relatively high doses. Compared with published data and DAP measured in a few other Dutch hospitals, the radiation burden of MCU is low at the JKZ. This indicates a good degree of optimization with respect to radiation protection (e.g. modern equipment, increased tube voltage, fast film-screen combination).

Entities:  

Mesh:

Year:  1999        PMID: 10624342     DOI: 10.1259/bjr.72.860.10624342

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Fluoroscopy-controlled voiding cystourethrography in infants and children: are the radiation risks trivial?

Authors:  Kostas Perisinakis; Maria Raissaki; John Damilakis; John Stratakis; John Neratzoulakis; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2005-12-03       Impact factor: 5.315

2.  Paediatric urological investigations--dose comparison between urology-related and CT irradiation.

Authors:  Mark Page; Cosmin Florescu; Lilian Johnstone; Daniel Habteslassie; Michael Ditchfield
Journal:  Pediatr Radiol       Date:  2013-02-05

3.  Ultra low-dose VCUG in children using a modern flat detectorunit.

Authors:  Sara Y S Linke; Ilias Tsiflikas; Klaus Herz; Phillipp Szavay; Sergios Gatidis; Jürgen F Schäfer
Journal:  Eur Radiol       Date:  2015-09-18       Impact factor: 5.315

4.  Effective dose estimation for pediatric voiding cystourethrography using an anthropomorphic phantom set and metal oxide semiconductor field-effect transistor (MOSFET) technology.

Authors:  Ryan Lee; Karen E Thomas; Bairbre L Connolly; Michelle Falkiner; Christopher L Gordon
Journal:  Pediatr Radiol       Date:  2009-02-25

5.  Echocontrast cystosonography versus micturating cystourethrography in the detection of vesicoureteric reflux.

Authors:  Mz Faizah; Y Kanaheswari; Cr Thambidorai; Ma Zulfiqar
Journal:  Biomed Imaging Interv J       Date:  2011-01-01

6.  Patient radiation exposure during general fluoroscopy examinations.

Authors:  Jeska S Wambani; Geoffrey K Korir; Mark A Tries; Ian K Korir; Jedidah M Sakwa
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

7.  Persistence and recurrence of vesicoureteric reflux in children after endoscopic therapy - implications of a risk-adapted follow-up.

Authors:  Bernhard Haid; Christoph Berger; Judith Roesch; Tanja Becker; Mark Koen; Werner Langsteger; Josef Oswald
Journal:  Cent European J Urol       Date:  2015-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.